During the past decade, Morales Vargas Centro de Investigacion, S.C. conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 8 clinical trials were completed, i.e. on average, 47.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Morales Vargas Centro de Investigacion, S.C." #1 sponsor was "Takeda" with 4 trials, followed by "EMD Serono" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Morales Vargas Centro de Investigacion, S.C." #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Janssen Pharmaceutica" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "National Health and Medical Research Council, Australia" with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Morales Vargas Centro de Investigacion, S.C." are "Systemic Lupus Erythematosus" (6 trials), "Colitis, Ulcerative" (3 trials), "Lupus Erythematosus, Systemic" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "Crohn's Disease" (2 trials). Many other conditions were trialed in "Morales Vargas Centro de Investigacion, S.C." in a lesser frequency.

Most popular intervention types in "Morales Vargas Centro de Investigacion, S.C." are "Drug" (17 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Amivantamab" (2 trials), "Atacicept 150 mg" (2 trials), "Baricitinib" (2 trials) and "Lazertinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Morales Vargas Centro de Investigacion, S.C." are 18 trials for "All" genders.

Currently, there are NaN active trials in "Morales Vargas Centro de Investigacion, S.C.". undefined are not yet recruiting, 1 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in Morales Vargas Centro de Investigacion, S.C., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Morales Vargas Centro de Investigacion, S.C., 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".